Norinchukin Bank’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.05M Buy
66,328
+397
+0.6% +$6.15K 0.01% 440
2026
Q1
$891K Sell
65,931
-265
-0.4% -$3.71K 0.01% 456
2025
Q4
$824K Buy
66,196
+3,159
+5% +$34.1K 0.01% 472
2025
Q3
$624K Sell
63,037
-1,105
-2% -$10.8K 0.01% 486
2025
Q2
$573K Buy
64,142
+3,120
+5% +$26.4K 0.01% 492
2025
Q1
$532K Buy
61,022
+7,956
+15% +$83.5K 0.01% 489
2024
Q4
$661K Buy
53,066
+4,231
+9% +$52K 0.01% 437
2024
Q3
$567K Buy
48,835
+6,818
+16% +$78.7K 0.01% 454
2024
Q2
$447K Buy
42,017
+2,338
+6% +$25.8K 0.01% 450
2024
Q1
$474K Sell
39,679
-509
-1% -$6.13K 0.01% 451
2023
Q4
$435K Sell
40,188
-930
-2% -$8.9K 0.01% 456
2023
Q3
$405K Sell
41,118
-14,414
-26% -$150K 0.01% 466
2023
Q2
$554K Sell
55,532
-20,700
-27% -$198K 0.01% 491
2023
Q1
$733K Buy
76,232
+2,363
+3% +$26.2K 0.01% 432
2022
Q4
$822K Sell
73,869
-16,574
-18% -$173K 0.02% 397
2022
Q3
$771K Buy
90,443
+9,639
+12% +$94.9K 0.02% 421
2022
Q2
$846K Sell
80,804
-31,055
-28% -$340K 0.02% 407
2022
Q1
$1.22M Buy
111,859
+9,412
+9% +$124K 0.02% 420
2021
Q4
$1.39M Sell
102,447
-608
-0.6% -$8.12K 0.02% 384
2021
Q3
$1.4M Buy
103,055
+3,046
+3% +$43.2K 0.02% 374
2021
Q2
$1.43M Sell
100,009
-396
-0.4% -$5.73K 0.02% 363
2021
Q1
$1.4M Buy
100,405
+1,666
+2% +$27.2K 0.02% 354
2020
Q4
$1.85M Buy
98,739
+55,349
+128% +$903K 0.03% 269
2020
Q3
$643K Buy
43,390
+577
+1% +$9.21K 0.01% 422
2020
Q2
$688K Sell
42,813
-379
-0.9% -$6.14K 0.01% 414
2020
Q1
$644K Sell
43,192
-25,145
-37% -$482K 0.01% 392
2019
Q4
$1.37M Sell
68,337
-7,688
-10% -$143K 0.02% 404
2019
Q3
$1.5M Buy
76,025
+1,861
+3% +$36.5K 0.02% 396
2019
Q2
$1.41M Sell
74,164
-25,175
-25% -$557K 0.02% 405
2019
Q1
$2.81M Buy
99,339
+3,415
+4% +$99.6K 0.04% 308
2018
Q4
$2.63M Buy
95,924
+29,610
+45% +$959K 0.04% 292
2018
Q3
$2.43M Buy
66,314
+7,912
+14% +$297K 0.03% 278
2018
Q2
$2.11M Buy
58,402
+11,233
+24% +$441K 0.03% 268
2018
Q1
$1.94M Buy
47,169
+4,292
+10% +$183K 0.03% 255
2017
Q4
$1.81M Buy
42,877
+2,961
+7% +$113K 0.03% 259
2017
Q3
$1.25M Buy
39,916
+7,929
+25% +$269K 0.02% 324
2017
Q2
$1.24M Buy
31,987
+2,061
+7% +$79.1K 0.03% 320
2017
Q1
$1.17M Buy
29,926
+2,009
+7% +$81K 0.03% 318
2016
Q4
$1.06M Buy
27,917
+3,289
+13% +$122K 0.02% 316
2016
Q3
$939K Buy
24,628
+2,230
+10% +$99.1K 0.02% 324
2016
Q2
$968K Buy
22,398
+1,244
+6% +$55K 0.02% 305
2016
Q1
$980K Buy
21,154
+1,856
+10% +$89.6K 0.02% 306
2015
Q4
$1.04M Sell
19,298
-4,325
-18% -$208K 0.03% 277
2015
Q3
$951K Buy
23,623
+321
+1% +$17.9K 0.02% 318
2015
Q2
$1.58M Buy
23,302
+1,194
+5% +$84.4K 0.04% 259
2015
Q1
$1.31M Buy
22,108
+54
+0.2% +$3.08K 0.03% 291
2014
Q4
$1.24M Buy
22,054
+7,036
+47% +$378K 0.03% 286
2014
Q3
$683K Buy
15,018
+1,071
+8% +$52.1K 0.02% 271
2014
Q2
$719K Sell
13,947
-1,442
-9% -$70.9K 0.02% 236
2014
Q1
$751K Buy
15,389
+1,088
+8% +$52.8K 0.02% 238
2013
Q4
$621K Sell
14,301
-39
-0.3% -$1.6K 0.02% 251
2013
Q3
$547K Buy
14,340
+1,141
+9% +$40.2K 0.02% 268
2013
Q2
$410K Buy
+13,199
New +$394K 0.01% 297

Other funds holding VTRS

Norinchukin Bank's VTRS Position: Q2 2026 in Review

Norinchukin Bank increased its Viatris (VTRS) stake by 0.6% in Q2 2026, buying an estimated $6.15K and bringing the position to 66,328 shares worth $1.05M. The position accounts for 0.01% of the portfolio, ranked #440.

Norinchukin Bank first reported a position in VTRS in Q2 2013 and has held it in 53 quarters since. The position peaked at $2.81M in Q1 2019. 1,024 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Norinchukin Bank held 66,328 shares of Viatris worth $1.05M as of Q2 2026.
  • Norinchukin Bank bought 397 Viatris shares in Q2 2026, an estimated $6.15K.
  • Viatris made up 0.01% of Norinchukin Bank's portfolio in Q2 2026, its #440 holding.
  • Norinchukin Bank first reported a position in Viatris in Q2 2013 and has held it in 53 quarters since.
  • Norinchukin Bank's Viatris position peaked at $2.81M in Q1 2019.
  • 1,024 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Norinchukin Bank's 13F filing for Q2 2026, filed 14 Aug 2026.